-
-
-
-
-
-
-
Cassava Sciences Reports 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, Amylyx, Sunnova, and DICK’S Sporting Goods and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, and Amylyx and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates
-
-
-
-
-
-
-
Pre-Open Movers: Target, Lowe's Trade in Opposite Directions Post Earnings
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Cassava, and Hannon Armstrong and Encourages Investors to Contact the Firm
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

